Literature DB >> 15917957

Atherogenic lipid profile of Brazilian near-term newborns.

I M C G Pardo1, B Geloneze, M A Tambascia, A A Barros-Filho.   

Abstract

Cardiovascular disease is the primary cause of death in Brazil. Recent studies have shown that low birth weight and preterm birth are linked to a higher prevalence of cardiovascular disease. The aim of the present study was to compare the levels of lipids and apolipoproteins and atherogenic indexes between term and near-term newborn infants. A sample of umbilical cord blood was obtained from 135 newborns (66 males) divided into two groups: 25 near-term neonates (35-36.6 weeks of gestational age) and 110 term neonates (37-42 weeks of gestational age). The total cholesterol concentrations were higher in the near-term neonates than in the term group (94.04 +/- 8.02 vs 70.42 +/- 1.63 mg/dl, P < 0.01), due to an increase in the LDL-cholesterol fraction in the near-term group (57.76 +/- 6.39 vs 34.38 +/- 1.29 mg/dl, P < 0.001). The atherogenic indexes (total cholesterol/HDL-cholesterol, LDL-cholesterol/HDL-cholesterol and apolipoprotein B/apolipoprotein A-I) were higher in the near-term group (P < 0.001, P < 0.001, and P < 0.05, respectively). The gestational age of the newborns was inversely correlated with total cholesterol and LDL-cholesterol, and also with the total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol indexes. These findings demonstrate that the lipid profile is worse in the group of near-term neonates compared with the term group. Future studies are needed to determine if this atherogenic profile in near-term neonates can affect body metabolism, increasing the risk for cardiovascular diseases in adult life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917957     DOI: 10.1590/s0100-879x2005000500013

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Comparison of Cord Blood Lipid Profile in Preterm Small for Gestational Age and Appropriate for Gestational Age Newborns.

Authors:  Tejasree Katragadda; Rajesh Shimoga Mahabala; Subodh Shetty; Shantharam Baliga
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Cord-blood lipoproteins, homocysteine, insulin sensitivity/resistance marker profile, and concurrence of dysglycaemia and dyslipaemia in full-term neonates of the Mérida Study.

Authors:  Eva Gesteiro; Sara Bastida; Francisco J Sánchez-Muniz
Journal:  Eur J Pediatr       Date:  2013-02-15       Impact factor: 3.183

3.  Lipid profile in neonates and its relation with birth weight and gestational age.

Authors:  Savitha Mysore Ramaraj; A P Bharath; K M Sanjay
Journal:  Indian J Pediatr       Date:  2014-12-24       Impact factor: 1.967

4.  Characterization of lipoproteins and associated lipidome in very preterm infants: a pilot study.

Authors:  Alice Küster; Mikael Croyal; Thomas Moyon; Dominique Darmaun; Khadija Ouguerram; Véronique Ferchaud-Roucher
Journal:  Pediatr Res       Date:  2022-06-23       Impact factor: 3.756

5.  Correlation of cord blood lipid heterogeneity in neonates with their anthropometry at birth.

Authors:  Chandrika D Nayak; Vaibhav Agarwal; Dinesh M Nayak
Journal:  Indian J Clin Biochem       Date:  2012-08-28

6.  Insulin resistance markers in term, normoweight neonates. The Mérida cohort.

Authors:  Eva Gesteiro; Sara Bastida; Francisco J Sánchez-Muniz
Journal:  Eur J Pediatr       Date:  2008-07-03       Impact factor: 3.183

7.  Gestational age and risk factors for cardiovascular disease: evidence from the 1958 British birth cohort followed to mid-life.

Authors:  Rachel Cooper; Kate Atherton; Chris Power
Journal:  Int J Epidemiol       Date:  2008-07-25       Impact factor: 7.196

8.  Cord blood lipid profile in a population of Iranian term newborns.

Authors:  Zohreh Badiee; Roya Kelishadi
Journal:  Pediatr Cardiol       Date:  2007-11-29       Impact factor: 1.655

9.  Cord blood lipoprotein profile in term, preterm, and late preterm newborns.

Authors:  Sedigheh Ghaemi; Raziyeh Najafi; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.